Catheter Precision, Inc. (VTAK)
(Delayed Data from AMEX)
$0.51 USD
-0.01 (-1.64%)
Updated Jun 10, 2024 03:57 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Income Statements
Fiscal Year end for Catheter Precision, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 0 | 0 | 0 | 4 | 7 |
Cost Of Goods | 0 | 0 | 2 | 5 | 9 |
Gross Profit | 0 | 0 | -2 | -1 | -2 |
Selling & Adminstrative & Depr. & Amort Expenses | 79 | 27 | 28 | 35 | 56 |
Income After Depreciation & Amortization | -78 | -27 | -29 | -36 | -58 |
Non-Operating Income | 8 | 0 | 2 | 0 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -71 | -27 | -27 | -36 | -57 |
Income Taxes | 0 | 0 | 0 | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -71 | -27 | -27 | -36 | -57 |
Extras & Discontinued Operations | 0 | 0 | 2 | 0 | 0 |
Net Income (GAAP) | -71 | -27 | -25 | -36 | -57 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -76 | -27 | -28 | -34 | -56 |
Depreciation & Amortization (Cash Flow) | 2 | 0 | 2 | 2 | 2 |
Income After Depreciation & Amortization | -78 | -27 | -29 | -36 | -58 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 5.50 | NA | 0.10 | 0.03 | 0.01 |
Diluted EPS Before Non-Recurring Items | -12.09 | NA | -289.50 | -1,061.00 | -5,412.50 |
Diluted Net EPS (GAAP) | -12.99 | -25.98 | -248.00 | -1,061.00 | -5,412.50 |
Fiscal Year end for Catheter Precision, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | 0.08 | 0.13 | 0.13 | 0.10 | 0.09 |
Cost Of Goods | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
Gross Profit | 0.08 | 0.12 | 0.13 | 0.09 | 0.08 |
SG&A, R&D, and Dept/Amort Expenses | 2.70 | 2.72 | 2.86 | 6.40 | 66.56 |
Income After SG&A, R&D, and Dept/Amort Expenses | -2.62 | -2.60 | -2.73 | -6.31 | -66.48 |
Non-Operating Income | -0.06 | 1.93 | 0.80 | 4.73 | 0.08 |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | -2.68 | -0.67 | -1.93 | -1.58 | -66.40 |
Income Taxes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -2.68 | -0.67 | -1.93 | -1.58 | -66.40 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -2.68 | -0.67 | -1.93 | -1.58 | -66.40 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | 7.43 | NA | 6.81 | 5.36 | NA |
Diluted EPS Before Non-Recurring Items | -0.36 | NA | -0.28 | 0.61 | NA |
Diluted Net EPS (GAAP) | -0.36 | 12.23 | -0.28 | -0.29 | -24.65 |